Price (delayed)
$5.0444
Market cap
$15.26M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$141.56
Enterprise value
$9.85M
onconova therapeutics, inc. (nasdaq: ontx) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. using a proprietary chemistry platform, onconova has
There are no recent dividends present for TRAW.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.